Vimentin Triple Negative Breast Cancer

Short Report Targeting EGFR In Triple Negative Breast Cancer
Targeting EGFR in Triple Negative Breast Cancer vimentin and fibronectin).7, 8 It has been proposed that EMT-like processes allow tumor cells to disassemble and mi-grate to tissue or organ sites distant from the primary tumor ... Visit Document

Mouse Mammary Stem Cells Express Prognostic Markers For ...
Markers for triple-negative breast cancer Kelly J Soady1,2, Howard Kendrick3, Qiong Gao1, Andrew Tutt4,5, TNBC: triple-negative breast cancer; Vim: vimentin. Competing interests The authors declare that they have no competing interests in the publication of this manuscript. Authors ... Read More

TRIPLE NEGATIVE BREAST CANCER - Eska
TRIPLE NEGATIVE BREAST CANCER •• Particular subtype of Breast Cancer, Biologicaly distinct and Molecularly defined. •• GENE EXPRESSION PROFILE OF BREAST CA.: ... Access Doc

Management Of triple negative breast cancer - Pittsburgh, PA
Review Management of triple negative breast cancer Catherine Oakmana, Giuseppe Vialeb, Angelo Di Leoa,* aSandro Pitigliani Medical Oncology Unit, Department of Oncology, Hospital of Prato, Istituto Toscano Tumori, Piazza Ospedale 2, 59100 Prato, Italy ... Access Full Source

2013 OPEN ACCESS International Journal Of Molecular Sciences
International Journal of Molecular Sciences ISSN 1422-0067 www.mdpi.com/journal/ijms Article TMPRSS4 as a Poor Prognostic Factor for Triple-Negative transmembrane protease; triple-negative breast cancer; prognosis; immunohistochemistry ... Get Doc

Vimentin, Zeb1 And Sip1 Are Up-regulated In triple-negative ...
Triple-negative breast cancer (TNBC) is a tumour showing no oestrogen (ER) or progesterone (PR) receptor positivity and no HER2 amplification [1, 2]. It accounts for 15–20 % vimentin in invasive breast cancer cells (p = 9.3 9 10-12) (Table 3). ... Retrieve Doc

Uncovering The Role Of TGFβ And BMP In Triple Negative Breast ...
Uncovering the Role of TGFβ and BMP in Triple Negative Breast Cancer Stem Cells Busra Gungor, Philip Owens, and Harold L. Moses KEYWORDS. Cancer stem cells, TGFβ, breast cancer, DMH1 BRIEF. BMP and TGFβ can dually support EMT and enhance cancer stem cell characteristics. ... View This Document

Vimentin ERK Signaling Uncouples Slug Gene Regulatory Function
Mammary stem cell state and regulate human breast cancer stem cells (9). Vimentin is abundantly expressed in stem cells and is induced alongside Slug during conversion of luminal mammary survival in triple-negative breast cancer patients. Oncologist 2012;17: 766–74. 32. ... Access This Document

Triple-Negative Breast Cancers: The Search For Targets
Triple Negative Breast Cancer Cells. IGF1R. IRS-1. Vimentin. GAPDH. HER2- (Triple Negative) Early-stage Breast Cancer. Early Stage . Triple Negative. BreastCancer. Surgery. Biopsy. Cisplatin. 75 mg/m2 q3wk x 4 cycles. Paclitaxel . 175 mg/m2 q2wk x 4 cycles. ... Get Document

A Review Of Triple-Negative Breast Cancer
Ease.1 Triple-negative breast cancer (TNBC) accounts triple-negative invasive breast tumors, researchers found P-cadherin, vimentin, epidermal growth factor recep-tor 1 (EGFR1 [or HER1]), c-kit, and other growth factors ... Doc Retrieval

Journal Of Experimental & Clinical Cancer Research BioMed Central
Journal of Experimental & Clinical Cancer Research 2009, markers including vimentin in a triple negative group. We non-triple negative breast cancer is reduced with longer follow-up period [34]. When basal phenotype markers ... Access Full Source

Triple-negative vimentin-positive Heterogeneous Feline ...
RESEARCH ARTICLE Open Access Triple-negative vimentin-positive heterogeneous feline mammary carcinomas as a potential comparative model for breast cancer ... Access This Document

Vimentin-ERK Signaling Uncouples Slug Gene Regulatory Function
Vimentin-ERK signaling uncouples Slug gene regulatory function Reetta Virtakoivu1,2, Anja Mai1, vimentin, EMT, ERK2, Slug, breast cancer characteristics are enriched in the aggressive and metastatic triple-negative breast cancer ... Access Doc

Nottingham Prognostic Index In Triple-Negative Breast Cancer ...
Nottingham Prognostic Index in Triple-Negative Breast Cancer: a reliable prognostic tool? André Albergaria1, Sara Ricardo1,2, Fernanda Milanezi1, using Nottingham Prognostic Index as a tool for triple-negative breast cancer prognostication. ... Return Doc

HER2/neu - Wikipedia, The Free Encyclopedia
For HER2-negative tumours, AACR Cancer Concepts Factsheet on HER2; Breast Friends for Life Network - A South African Breast Cancer Support Forum for HER2 Positive Women; HerceptinR : Vimentin; Carcinoma : Cytokeratin; Musculoskeletal: ... Read Article

Phyllodes - Breast Cancer Tumor
Overview of Phyllodes Breast Tumor: Phyllodes tumor is a very rare type of breast tumor, which can be benign (harmless) or malignant (cancerous). ... Read Article

Triple Negative Breast Cancer Treatment: Use Of Platinum And ...
Triple Negative Breast Cancer Treatment: Use of Platinum and Platinum Analogs 779. antiblastic drugs has been made by numerous authors. The Cancer and Leukemia Group B reported a benefit ... Access Full Source

Triple-negative breast cancers: An Updated Review On ...
Diagnosed with breast cancer 1–4. More recently, gene Patients with triple-negative breast cancers therefore triple-negative breast tumours. KEY WORDS Triple-negative breast tumours, epidermal growth factor receptor, chemotherapy ... Retrieve Document

What Is triple-negative breast cancer?
Since triple-negative breast cancer is resistant to our cur-rent HER2-targeted therapies such as trastuzumab, and hor-monal therapies such as tamoxifen and aromatase inhibitors, chemotherapy is the mainstay of treatment. This ... Fetch Here

Preoperative Treatment Of The Triple Negative (Basal ...
Negative (Basal Phenotype) Breast Cancer. Judy E. Garber, MD MPH Dana Farber Cancer Institute. Vimentin • Little DCIS • Poor prognosis • Different stem cell? in Triple Negative Breast Cancer. PI: J Garber, MD MPH, DFCI: DF/HCC, Val D’Hebron. Women with . ... Document Viewer

Vimentin As A Poor Prognostic Factor For triple-negative ...
ORIGINAL PAPER Vimentin as a poor prognostic factor for triple-negative breast cancer Nami Yamashita • Eriko Tokunaga • Hiroyuki Kitao • Yuichi Hisamatsu• ... Return Document

Question 1 - SignUp4
Triple Negative Breast Cancer Laura C. Collins, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA Question 1 • The tumor depicted on the next slide is from a 42 year old woman with a BRCA1 • Vimentin positive However, not an immunophenotypically homogeneous ... Fetch Content